Skip to main content
Article thumbnail
Location of Repository

Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in China

By Kui Hong, An-Hui Gao, Qing-Yi Xie, Hao Gao, Ling Zhuang, Hai-Peng Lin, Hai-Ping Yu, Jia Li, Xin-Sheng Yao, Michael Goodfellow and Ji-Sheng Ruan


The mangrove ecosystem is a largely unexplored source for actinomycetes with the potential to produce biologically active secondary metabolites. Consequently, we set out to isolate, characterize and screen actinomycetes from soil and plant material collected from eight mangrove sites in China. Over 2,000 actinomycetes were isolated and of these approximately 20%, 5%, and 10% inhibited the growth of Human Colon Tumor 116 cells, Candida albicans and Staphylococcus aureus, respectively, while 3% inhibited protein tyrosine phosphatase 1B (PTP1B), a protein related to diabetes. In addition, nine isolates inhibited aurora kinase A, an anti-cancer related protein, and three inhibited caspase 3, a protein related to neurodegenerative diseases. Representative bioactive isolates were characterized using genotypic and phenotypic procedures and classified to thirteen genera, notably to the genera Micromonospora and Streptomyces. Actinomycetes showing cytotoxic activity were assigned to seven genera whereas only Micromonospora and Streptomyces strains showed anti-PTP1B activity. We conclude that actinomycetes isolated from mangrove habitats are a potentially rich source for the discovery of anti-infection and anti-tumor compounds, and of agents for treating neurodegenerative diseases and diabetes

Topics: Article
Publisher: Molecular Diversity Preservation International
OAI identifier:
Provided by: PubMed Central

Suggested articles

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.